Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach.
about
Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecanBravo/Nr-CAM is closely related to the cell adhesion molecules L1 and Ng-CAM and has a similar heterodimer structureThe synaptic vesicle protein SV2 is complexed with an alpha5-containing laminin on the nerve terminal surfaceHeparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7)Synthesis of Anticoagulantly Active Heparan Sulfate Proteoglycans by Glomerular Epithelial Cells Involves Multiple 3-O-Sulfotransferase Isoforms and a Limiting Precursor PoolUsing an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures.Substrate specificity of 6-O-endosulfatase (Sulf-2) and its implications in synthesizing anticoagulant heparan sulfate.Raman spectroscopic investigation of peptide-glycosaminoglycan interactions.Control growth factor release using a self-assembled [polycation:heparin] complex.Chemoenzymatic design of heparan sulfate oligosaccharidesChemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharidesChemoenzymatic synthesis of homogeneous ultralow molecular weight heparinsHeparin-protein interactions.Aponecrotic, antiangiogenic and antiproliferative effects of a novel dextran derivative on breast cancer growth in vitro and in vivoHomogeneous low-molecular-weight heparins with reversible anticoagulant activity.Proteoglycans in cell regulation.Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approachMapping the heparin-binding sites on type I collagen monomers and fibrils.Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation.Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1.Possible regulation of FGF activity by syndecan, an integral membrane heparan sulfate proteoglycan.Carbohydrate-protein interactions and their biosensing applications.New targets for glycosaminoglycans and glycosaminoglycans as novel targets.6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture.Epidermal transformation leads to increased perlecan synthesis with heparin-binding-growth-factor affinity.Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.Characterization of the heparin-binding site of the mycobacterial heparin-binding hemagglutinin adhesin.Characterization and hormonal modulation of anticoagulant heparan sulfate proteoglycans synthesized by rat ovarian granulosa cells.Syndecan-1 and -4 synthesized simultaneously by mouse mammary gland epithelial cells bear heparan sulfate chains that are apparently structurally indistinguishable.High affinity glycosaminoglycan and autoantigen interaction explains joint specificity in a mouse model of rheumatoid arthritisThe cartilage-specific fibronectin isoform has a high affinity binding site for the small proteoglycan decorin.Heparinase I from Flavobacterium heparinum. Mapping and characterization of the heparin binding domain.Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.Identification of an invasion regulatory domain within the core protein of syndecan-1.Insulin-like growth factor (IGF) binding protein-3 regulation of IGF-I is altered in an acidic extracellular environment.Multiple heparan sulfate chains are required for optimal syndecan-1 function.Analysis of bacteriophage N protein and peptide binding to boxB RNA using polyacrylamide gel coelectrophoresis (PACE).Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesionStructural domains of heparan sulphate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEPII).Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4.
P2860
Q24313450-33024A18-BF7E-423F-9B88-A32F416AB8B2Q27485693-CC525B7F-59B8-42A5-8CF9-C424D03E3CD2Q28141654-9B16C407-ABFE-4052-8547-5731E6019328Q28564762-644E1A0C-9D5F-46D9-93A4-185103A5EB57Q29041276-70D10BEB-6E7E-4DC9-90E3-C4FAA2AA486BQ33299802-46D1A0F9-4096-45F2-88B1-DB0370BFFB56Q33401779-EFCD491E-C6BD-46E2-BCA8-E7482439F70AQ33468739-4C247E69-05FB-461E-A4BC-C4AA557D2805Q33603057-418907EA-4803-4BE2-919F-63C2CF09CA82Q33668533-86B57EF0-48AE-4E71-979D-891BF6603F83Q33806757-51ECD868-380C-4FBE-9100-1D39EA3D8E30Q34228210-9EAD070B-8E04-4358-8516-73381DBBD69BQ35030190-2245FF6E-0C39-4E94-9370-DF6D2CBB42CCQ35044298-423F0276-A5D1-41DD-B412-2813F84B8FB5Q35361517-27443D10-1F8D-493E-8E7B-BDD7E20D529BQ35452819-40C56AB3-A823-48F9-8BE9-ED09BEF0CE4CQ35591462-73010678-36BA-4BE6-9C07-CB10682039DEQ36234227-396F50B0-067B-465C-842E-129671BA3E46Q36483511-546B0A4C-EE85-4BCE-9A13-786214C485AEQ36825044-ECA52B92-4C5F-4A58-89EE-F5A6F191BE07Q36940861-26EED4B5-B716-455E-81F0-46AA178B22E4Q37971453-E891BFA0-4854-4389-A5D2-4CDCD456DFCFQ38081956-954BCDA2-AD61-4ECF-90C4-6FFB37D527EDQ38293479-BCAEFBAC-DF5D-460E-9DEE-515CFEE07425Q38302299-305B643F-403B-4204-9CD4-03F246794B1BQ38302571-4C33C4A9-FE8E-41FD-A15F-18C5DA93B02FQ38312566-D80FB524-D6E1-4813-B9A3-36EA45466877Q38353168-3B3A37E5-F734-4921-8359-AFCAEC037AEFQ38357933-5B10C6C5-D2A2-41F6-AE17-2420E546534EQ38359753-19F116A7-F4E9-4B63-9739-81FDA6EF421FQ38359775-9B9C7775-74D3-4D0B-9BF1-89B9D525E7EBQ38361800-E7FD40DE-3A20-478E-AFF2-3ABF378C84E8Q39115074-F392D0AB-979E-46D1-9195-B7F9010D0938Q40488299-BDCF8C96-9C03-45AB-9BA8-9DC0500AAA88Q40762533-390426B9-CFF7-4DC4-A5BB-C2D882B13D32Q40999078-B74D4396-1B1E-4601-9E5B-3BFBD59BA751Q41836817-51DDB5CE-2EEF-4BAC-B166-6154A61C4232Q41896828-BA158B24-CE99-46E5-BF32-8F306C2291E5Q42160055-F1CB4D19-B22C-4E47-9DE2-9E42CDB5BCE9Q42671834-56729104-D4F3-4FC5-84BF-18DD6328EF4B
P2860
Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Analysis of affinity and struc ...... tive electrophoretic approach.
@en
Analysis of affinity and struc ...... tive electrophoretic approach.
@nl
type
label
Analysis of affinity and struc ...... tive electrophoretic approach.
@en
Analysis of affinity and struc ...... tive electrophoretic approach.
@nl
prefLabel
Analysis of affinity and struc ...... tive electrophoretic approach.
@en
Analysis of affinity and struc ...... tive electrophoretic approach.
@nl
P2860
P356
P1476
Analysis of affinity and struc ...... tive electrophoretic approach.
@en
P2093
P2860
P304
P356
10.1073/PNAS.88.7.2768
P407
P577
1991-04-01T00:00:00Z